Cargando…
The stress-responsive kinase DYRK2 activates heat shock factor 1 promoting resistance to proteotoxic stress
To survive proteotoxic stress, cancer cells activate the proteotoxic-stress response pathway, which is controlled by the transcription factor heat shock factor 1 (HSF1). This pathway supports cancer initiation, cancer progression and chemoresistance and thus is an attractive therapeutic target. As d...
Autores principales: | Moreno, Rita, Banerjee, Sourav, Jackson, Angus W., Quinn, Jean, Baillie, Gregg, Dixon, Jack E., Dinkova-Kostova, Albena T., Edwards, Joanne, de la Vega, Laureano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166837/ https://www.ncbi.nlm.nih.gov/pubmed/33268814 http://dx.doi.org/10.1038/s41418-020-00686-8 |
Ejemplares similares
-
The Role of Sulfhydryl Reactivity of Small Molecules for the Activation of the KEAP1/NRF2 Pathway and the Heat Shock Response
por: Dinkova-Kostova, Albena T.
Publicado: (2012) -
Emerging roles of DYRK2 in cancer
por: Tandon, Vasudha, et al.
Publicado: (2021) -
Dual inhibition of HSF1 and DYRK2 impedes cancer progression
por: Tandon, Vasudha, et al.
Publicado: (2023) -
The heat shock protein LarA activates the Lon protease in response to proteotoxic stress
por: Omnus, Deike J., et al.
Publicado: (2023) -
High NRF2 Levels Correlate with Poor Prognosis in Colorectal Cancer Patients and with Sensitivity to the Kinase Inhibitor AT9283 In Vitro
por: Torrente, Laura, et al.
Publicado: (2020)